Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The rs61764370 Functional Variant in the KRAS Oncogene is Associated with Chronic Myeloid Leukemia Risk in Women.
Gutiérrez-Malacatt H, Ayala-Sanchez M, Aquino-Ortega X, Dominguez-Rodriguez J, Martinez-Tovar A, Olarte-Carrillo I, Martinez-Hernandez A, C CC, Orozco L, Cordova EJ. Gutiérrez-Malacatt H, et al. Among authors: ayala sanchez m. Asian Pac J Cancer Prev. 2016;17(4):2265-70. doi: 10.7314/apjcp.2016.17.4.2265. Asian Pac J Cancer Prev. 2016. PMID: 27221928 Free article.
Global gene expression profiles of hematopoietic stem and progenitor cells from patients with chronic myeloid leukemia: the effect of in vitro culture with or without imatinib.
Avilés-Vázquez S, Chávez-González A, Hidalgo-Miranda A, Moreno-Lorenzana D, Arriaga-Pizano L, Sandoval-Esquivel MÁ, Ayala-Sánchez M, Aguilar R, Alfaro-Ruiz L, Mayani H. Avilés-Vázquez S, et al. Among authors: ayala sanchez m. Cancer Med. 2017 Dec;6(12):2942-2956. doi: 10.1002/cam4.1187. Epub 2017 Oct 13. Cancer Med. 2017. PMID: 29030909 Free PMC article.
Casiopeina III-Ea, a copper-containing small molecule, inhibits the in vitro growth of primitive hematopoietic cells from chronic myeloid leukemia.
Chavez-Gonzalez A, Centeno-Llanos S, Moreno-Lorenzana D, Sandoval-Esquivel MA, Aviles-Vazquez S, Bravo-Gomez ME, Ruiz-Azuara L, Ayala-Sanchez M, Torres-Martinez H, Mayani H. Chavez-Gonzalez A, et al. Among authors: ayala sanchez m. Leuk Res. 2017 Jan;52:8-19. doi: 10.1016/j.leukres.2016.11.001. Epub 2016 Nov 3. Leuk Res. 2017. PMID: 27855286
Functional integrity in vitro of hematopoietic progenitor cells from patients with chronic myeloid leukemia that have achieved hematological remission after different therapeutic procedures.
Chávez-González A, Ayala-Sánchez M, Sánchez-Valle E, Ruiz-Sánchez E, Arana-Trejo RM, Vela-Ojeda J, Mayani H. Chávez-González A, et al. Among authors: ayala sanchez m. Leuk Res. 2006 Mar;30(3):286-95. doi: 10.1016/j.leukres.2005.06.028. Epub 2005 Aug 18. Leuk Res. 2006. PMID: 16111748
Donor lymphocyte infusions for relapse of chronic myeloid leukemia after allogeneic stem cell transplantation: prognostic significance of the dose of CD3(+) and CD4(+) lymphocytes.
Vela-Ojeda J, García-Ruiz Esparza MA, Reyes-Maldonado E, Jiménez-Zamudio L, Moreno-Lafont M, García-Latorre E, Ramírez-Sanjuan E, Montiel-Cervantes L, Tripp-Villanueva F, García-León LD, Ayala-Sánchez M, Rosas-Cabral A, Aviña-Zubieta JA, Galindo-Rodríguez G, Vadillo-Buenfil M, Salazar-Exaire D. Vela-Ojeda J, et al. Ann Hematol. 2004 May;83(5):295-301. doi: 10.1007/s00277-003-0822-y. Epub 2003 Dec 5. Ann Hematol. 2004. PMID: 15060749
21 results